SecSonar.com

Stablecoin Development Corp. (SDEV)

Stablecoin Development Corp. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Stablecoin Development Corp. (SDEV) is a Medical - Pharmaceuticals company based in US with a market capitalization of $35M. Free cash flow was negative at -$8.4M. This page tracks SDEV's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 4 employees · IPO Apr 6, 2026

Valuation

Valuation & price

$1.68 · as of May 17, 2026 · -13.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.95$1.48$1.01Mar 26May 26Jul 26Mar 9, 26$1.24Mar 10, 26$1.26Mar 11, 26$1.27Mar 12, 26$1.27Mar 13, 26$1.21Mar 16, 26$1.45Mar 17, 26$1.36Mar 18, 26$1.28Mar 19, 26$1.22Mar 20, 26$1.16Mar 23, 26$1.38Mar 24, 26$1.50Mar 25, 26$1.42Mar 26, 26$1.53Mar 27, 26$1.50Mar 30, 26$1.35Mar 31, 26$1.49Apr 1, 26$1.59Apr 2, 26$1.95Apr 6, 26$1.88Apr 7, 26$1.70Apr 8, 26$1.74Apr 9, 26$1.58Apr 10, 26$1.60Apr 13, 26$1.64Apr 14, 26$1.66Apr 15, 26$1.57Apr 16, 26$1.50Apr 17, 26$1.54Apr 20, 26$1.40Apr 21, 26$1.38Apr 22, 26$1.39Apr 23, 26$1.29Apr 24, 26$1.33Apr 27, 26$1.31Apr 28, 26$1.26Apr 29, 26$1.27Apr 30, 26$1.24May 1, 26$1.31May 4, 26$1.31May 5, 26$1.43May 6, 26$1.65May 7, 26$1.53May 8, 26$1.63May 11, 26$1.65May 12, 26$1.74May 13, 26$1.78May 14, 26$1.64May 15, 26$1.64May 18, 26$1.59May 19, 26$1.55May 20, 26$1.52May 21, 26$1.48May 22, 26$1.41May 26, 26$1.31May 27, 26$1.40May 28, 26$1.31May 29, 26$1.27Jun 1, 26$1.21Jun 2, 26$1.15Jun 3, 26$1.16Jun 4, 26$1.21Jun 5, 26$1.12Jun 8, 26$1.16Jun 9, 26$1.04Jun 10, 26$1.07Jun 11, 26$1.09Jun 12, 26$1.01Jun 15, 26$1.08Jun 16, 26$1.11Jun 17, 26$1.19Jun 18, 26$1.22Jun 22, 26$1.14Jun 23, 26$1.15Jun 24, 26$1.11Jun 25, 26$1.12Jun 26, 26$1.11Jun 29, 26$1.05Jun 30, 26$1.05Jul 1, 26$1.04Jul 2, 26$1.36
$1.0152-week range$1.95
Loading valuation history…

Fundamentals

Key fundamentals

$35M

Market cap

—

Revenue growth (YoY)

58.2%

Gross margin

-$8.4M

Free cash flow (USD)

-$7.2M

Net debt

Net cash position

757.1%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$11.9MFY 2017$18.2MFY 2018$12.5MFY 2019$6.6MFY 2020$9.9MFY 2021$10.2MFY 2022$14.4MFY 2023$10.5MFY 2024$0.00FY 2025$0.00
$11.9M$0

Free cash flow by year

2016 → 2025

FY 2016$-12.3MFY 2017$-6.5MFY 2018$-5.6MFY 2019$-8.2MFY 2020$-4.8MFY 2021$-9.2MFY 2022$-6.8MFY 2023$-4.3MFY 2024$-7.5MFY 2025$-8.4M
-$12.3M-$8.4M

Gross margin by year

2021 → 2023

FY 202163.9%FY 202254.0%FY 202358.2%
63.9%58.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $0.10)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventWarrant IssuanceJun 17, 2026Filing
  • 8-K eventEarnings ReleaseMay 20, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing
  • 8-K eventFinancial Statement RestatementApr 29, 2026Filing
  • Annual report10-K FiledApr 29, 2026Filing
  • 8-K eventCorporate Name ChangeApr 6, 2026Filing
  • 8-K eventBylaws AmendedApr 1, 2026Filing

Questions

Frequently asked questions

What is Stablecoin Development Corp.'s market cap?

Stablecoin Development Corp. (SDEV) has a market capitalization of $35M.

What is SDEV's P/E ratio?

A meaningful P/E ratio is not available for SDEV — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did Stablecoin Development Corp. last report earnings?

SDEV last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying SDEV stock?

SEC Form 4 filings show no open-market insider buys at Stablecoin Development Corp. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Pharmaceuticals

NEUP

Neuphoria Therapeutics Inc.

$28.6M

KYNB

Kyntra Bio, Inc.

$28.1M

PETS

PetMed Express, Inc.

$46.7M

YI

111, Inc.

$47.9M

POM

POMDOCTOR Ltd

$12.7M

HKPD

Cellyan Biotechnology Co., Ltd

$5.7M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.